New

Europe Diltiazem Market

2021

Europe Diltiazem Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Capsules, Injection, and Tablets) and Application (Angina, Hypertension, and Others)

Publication Month: Oct 2021 | Report Code: TIPRE00025366 | No. of Pages: 126 | Category: Pharmaceuticals | Status: Published

Market Insights

Europe Diltiazem Market to Grow at a CAGR of 11.8% to reach US$ 207.38 million Million from 2021 to 2028

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Europe diltiazem market is expected to reach US$ 207.38 million by 2028 from US$ 95.08 million in 2021; it is estimated to grow at a CAGR of 11.8% from 2021 to 2028.


Rise in government initiatives for promotion, increase in the prevalence of cardiovascular diseases, and rise in the elderly population with heart diseases worldwide are expected to boost the market growth over the years. However, side effects of diltiazem on consumption are likely to negatively impact the growth of the market in the coming years.

Heart diseases are primarily observed in older adults due to their weak immunity and other major health problems. According to the Global Ageing 2019 survey, the world's population of 65 and above totaled 703 million in 2019. The elderly demographic is expected to double to 1.5 billion people by 2050. This demographic is more susceptible to Cardiovascular dieseses (CVDs) such as arrhythmias. The elderly population is more prompt to have atypical presentations, comorbid conditions, and unfavorable outcomes. Structural and functional changes in the cardiovascular system associated with aging are major causes of cardiovascular diseases. Therefore, the rising geriatric population worldwide is leading to an increase in the incidence of cardiovascular disease, bolstering the growth of the diltiazem market. Also, the diltiazem market is characterized by the presence of various small and big companies. The market players adopt new product launches, regional expansions, and product approvals to increase their market share. The players are investing in R&D to develop advanced technologies and gain significant revenue share in Europe. For instance, in March 2021, Glenmark Pharmaceuticals was granted competitive generic therapy (CGT) designation for Diltiazem Hydrochloride Extended-Release Capsules USP, 60 mg, 90 mg, and 120 mg; therefore, it is eligible for 180 days of CGT exclusivity upon commercial marketing. Thus, such recent developments are expected to act as a future trend in the diltiazem market

The European market is severely hit due to the exponential increase of COVID-19 cases in the region. The rising rate of COVID-19 is resulting in increased stress on the region's healthcare system, increasing the need for diagnostic tests in its healthcare system, encouraging the expansion of the sector in this region. Hypertension has been recorded in various cases and retrospective groups as a possible risk factor for the frequency and severity of COVID-19. Since the SARS-CoV-2's high infectivity rates, a possible interaction between COVID-19 and hypertension is worrisome. Diltiazem may be helpful to treat hypertension associated with COVID-19. Overall, diltiazem plays dual effects on hypertension-linked COVID-19 treatment by lowering high blood pressure and restraining NF-kb signaling pathway-related inflammation. The region witnessed some shortfall at the beginning of the COVID-19 crisis due to disruption in supply chain and demand due to lockdown announced by most European countries. Market players and end users lost their business due to the temporarily shutting down of industries in various regions. However, the diltiazem market witnessed growth during the pandemic as it is anticipated to inhibit viral growth and related hypertension.

Get more information on this report :



EUROPE DILTIAZEM MARKET SEGMENTATION

By Product Type

  • Tablet
  • Capsules
  • Injection

By Application

  • Hypertension
  • Angina
  • Others

By Country

  • Italy
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe

Company Profiles

  • Bausch Health Companies Inc.
  • Teva Pharmaceutical Industries Ltd
  • MYLAN N.V.
  • Pfizer Inc.
  • Sandoz (Novartis AG)
  • Sun Pharmaceutical Industries Ltd
  • Hikma Pharmaceuticals PLC
  • Zydus Cadila
  • Glenmark

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Diltiazem Market – By Product Type

1.3.2 Europe Diltiazem Market – By Application

1.3.3 Europe Diltiazem Market – By Country

2. Europe Diltiazem Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Diltiazem Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe– PEST Analysis

4.3 Experts Opinion

5. Diltiazem Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increase in Cardiovascular Disease Incidence

5.1.2 Increasing Elderly Population

5.2 Market Restraints

5.2.1 Side Effects of Diltiazem

5.3 Future Trends

5.3.1 Recent Developments in Market

5.4 Impact Analysis

6. Diltiazem Market – Europe Analysis

6.1 Europe Diltiazem Market Revenue Forecast and Analysis

7. Diltiazem Market Analysis and forecasts to 2028 – Product Type

7.1 Overview

7.2 Diltiazem Market Share by Product Type 2021 & 2028 (%)

7.3 Capsules

7.3.1 Overview

7.3.2 Capsules Market Revenue and Forecast to 2028 (US$ Mn)

7.4 Injection

7.4.1 Overview

7.4.2 Injection Market Revenue and Forecast to 2028 (US$ Mn)

7.5 Tablets

7.5.1 Overview

7.5.2 Tablet Market Revenue and Forecast to 2028 (US$ Mn)

8. Diltiazem Market Analysis and Forecasts To 2028 – Application

8.1 Overview

8.2 Diltiazem Market Share by Application 2021 & 2028 (%)

8.3 Angina

8.3.1 Overview

8.3.2 Angina Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Hypertension

8.4.1 Overview

8.4.2 Hypertension Market Revenue and Forecast to 2028 (US$ Mn)

8.5 Others

8.5.1 Overview

8.5.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

9. Diltiazem Market – Europe Analysis

9.1 Europe: Diltiazem Market

9.1.1 Europe: Diltiazem Market, by Country, 2021 & 2028 (%)

9.1.1.1 UK: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.1 UK: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.2 UK: Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

9.1.1.1.3 UK: Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)

9.1.1.2 Germany: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.1 Germany: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.2.2 Germany: Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

9.1.1.2.3 Germany: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

9.1.1.3 France: Diltiazem Market - Revenue and Forecasts to 2028 (USD Million)

9.1.1.3.1 France: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.3.2 France: Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

9.1.1.3.3 France: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

9.1.1.4 Spain: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.4.1 Spain: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.4.2 Spain: Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

9.1.1.4.3 Spain: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

9.1.1.5 Italy: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.5.1 Italy: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.5.2 Italy: Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

9.1.1.5.3 Italy: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

9.1.1.6 Rest of Europe: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.6.1 Rest of Europe: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

9.1.1.6.2 Rest of Europe: Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

9.1.1.6.3 Rest of Europe: Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Europe Diltiazem Market

10.1 Europe: Impact Assessment of COVID-19 Pandemic

11. Diltiazem Market–Industry Landscape

11.1 Overview

11.2 Recent Growth Strategies In The Diltiazem Market

12. Company Profiles

12.1 Bausch Health Companies Inc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Teva Pharmaceutical Industries Ltd

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 MYLAN N.V.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Pfizer Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Sandoz (Novartis AG)

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Sun Pharmaceutical Industries Ltd

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Hikma Pharmaceuticals PLC

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Zydus Cadila

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Glenmark

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms


LIST OF TABLES

Table 1. UK Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 2. UK Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 3. Germany Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 4. Germany Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 5. France Diltiazem Market, by Product Type– Revenue and Forecast to 2028 (USD Million)

Table 6. France Diltiazem Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 7. Spain Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 8. Spain Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 9. Italy Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 10. Italy Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 11. Rest of Europe Diltiazem Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 12. Rest of Europe Diltiazem Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 13. Glossary of Terms, Diltiazem Market


LIST OF FIGURES

Figure 1. Diltiazem Market Segmentation

Figure 2. Diltiazem Market Segmentation, By Country

Figure 3. Europe Diltiazem Market Overview

Figure 4. Tablets Held the Largest Share of the Product Segment in Diltiazem Market

Figure 5. Europe Diltiazem Market – Leading Country Markets (US$ Million)

Figure 6. Europe and PEST Analysis

Figure 7. Diltiazem Market: Impact Analysis of Drivers and Restraints

Figure 8. Europe Diltiazem Market – Revenue Forecast and Analysis – 2020- 2028

Figure 9. Diltiazem Market Share by Product Type 2021 & 2028 (%)

Figure 10. Capsules Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11. Injection Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. Tablet Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. Diltiazem Market Share by Application 2021 & 2028 (%)

Figure 14. Angina Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15. Hypertension Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. Europe: Diltiazem Market, by Key Country – Revenue (2021) (USD Million)

Figure 18. Europe: Diltiazem Market, by Country, 2021 & 2028 (%)

Figure 19. UK: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

Figure 20. Germany: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

Figure 21. France: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

Figure 22. Spain: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

Figure 23. Italy: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

Figure 24. Rest of Europe: Diltiazem Market – Revenue and Forecast to 2028 (USD Million)

Figure 25. Impact of COVID-19 Pandemic in European Country Markets

  1. Bausch Health Companies Inc.
  2. Teva Pharmaceutical Industries Ltd
  3. MYLAN N.V.
  4. Pfizer Inc.
  5. Sandoz (Novartis AG)
  6. Sun Pharmaceutical Industries Ltd
  7. Hikma Pharmaceuticals PLC
  8. Zydus Cadila
  9. Glenmark

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe diltiazem market.

- Highlights key business priorities in order to assist companies to realign their business strategies.

- The key findings and recommendations highlight crucial progressive industry trends in the Europe diltiazem market, thereby allowing players across the value chain to develop effective long-term strategies.

- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.

- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TIPRE00025366
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.